NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 9 filers reported holding NUVECTIS PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,671,499 | -7.0% | 129,663 | +15.2% | 0.00% | – |
| Q2 2023 | $1,797,199 | +291.4% | 112,536 | +221.3% | 0.00% | – |
| Q1 2023 | $459,138 | +195277.9% | 35,022 | +11.6% | 0.00% | – |
| Q4 2022 | $235 | -99.9% | 31,368 | -0.2% | 0.00% | – |
| Q3 2022 | $222,000 | -17.2% | 31,441 | +31.2% | 0.00% | – |
| Q2 2022 | $268,000 | +145.9% | 23,967 | +61.7% | 0.00% | – |
| Q1 2022 | $109,000 | – | 14,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ronit Capital LLP | 550,000 | $4,076,000 | 5.10% |
| Virtu Financial LLC | 11,365 | $84,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 20 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 14,822 | $109,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 42,160 | $312,000 | 0.00% |
| BlackRock Inc. | 7,872 | $59,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,750 | $13,000 | 0.00% |
| UBS Group AG | 141 | $1,000 | 0.00% |